Serum Inst to launch first indigenous vaccine against pneumonia

The first indigenous vaccine against pneumonia, developed by Serum Institute of India (SII), is slated to be launched by Union Health Minister Harsh Vardhan and made available in the domestic......

Bharat Biotech to make 900 million Covaxin vaccines

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.Sohini Das reports. IMAGE: Union Health Minister Harsh Vardhan shows......

FAQ: Is it safe to take antibody cocktail for Covid-19?

According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a......

GlaxoSmithKline back on health track

GlaxoSmithKline Consumer has a knack of springing surprises.It posted a healthy volume growth of about nine per cent in the December 2012 quarter when most other packaged foods companies struggled......

Govt clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

The government on Thursday cleared Rs 6,400-crore (Rs 64-billion) FDI proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. The Cabinet......

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......

HUL-GlaxoSmithKline merger leads to Rs 31,700 cr entity

The transaction is an all equity merger with 4.39 shares of HUL being allotted for every share in GlaxoSmithKline Consumer Healthcare India FMCG major HUL on Monday said its board has......